| Financial Year |
March 31 2023 |
| Monetary Funds |
87,512,192.22 |
| Held-for-trading Financial Assets |
150,000,000.00 |
| Notes Receivable |
3,600,000.00 |
| Accounts Receivable |
26,244,548.97 |
| Advances to Suppliers |
90,970,040.91 |
| Other Receivables |
3,197,946.47 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,036,512,984.57 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
67,012,631.87 |
| Total Current Assets |
1,467,527,092.33 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
20,939,371.40 |
| Investment Properties |
-- |
| Fixed Assetes |
135,892,980.20 |
| Under-construction Projects |
222,983,594.45 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
53,968,698.76 |
| R&D expenses |
-- |
| Goodwill |
73,764.87 |
| Long-Term Deferred and Prepaid Expenses |
2,697,412.86 |
| Deferred Income Tax Assets |
16,703,459.06 |
| Other Non-Current Assets |
41,490,765.62 |
| Sub-Total of Non-Current Assets |
495,587,450.21 |
| Total Assets |
1,963,114,542.54 |
| Short-Term Loans |
319,067,763.89 |
| Trading Financial liabilities |
54,016,725.66 |
| Notes Payable |
-- |
| Accounts Payable |
27,560,149.83 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
3,192,311.93 |
| Taxes Payable |
5,962,415.69 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
4,102,529.64 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
2,288,910.84 |
| Sub-Total of Current Liabilities |
430,590,613.36 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,347,793.54 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
26,274,761.52 |
| Total Liabilities |
456,865,374.88 |
| Paid-In Capital(Or Share Stock) |
113,333,334.00 |
| Capital Surplus |
573,082,924.20 |
| Surplus Reserve |
76,344,724.92 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
671,551,357.12 |
| Minority Stockholder's Interest |
71,936,827.42 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,434,312,340.24 |
| Owner's Equity（Stockholder's Equity） |
1,506,249,167.66 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,963,114,542.54 |
